Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | Cedars-Sinai Medical Center |
| Country | United States |
| Start Date | Jul 01, 2024 |
| End Date | Jul 31, 2026 |
| Duration | 760 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 11063653 |
PROJECT SUMMARY – Parent R01 CA268055 Cisplatin (Cis)-based Neoadjuvant chemotherapy (NAC) is the standard of care prior to cystectomy, for patients with muscle-invasive bladder cancer (MIBC). Up to 30% of patients respond and show no residual tumor at cystectomy with >80% survival, but “non responders” have
Cedars-Sinai Medical Center
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant